Over the past 12 months, 0 insiders at NOVAVAX INC filed 0 open-market SEC Form 4 transactions on NVAX: 0 purchases worth $0 and 0 sales worth $0. Insiders have been mixed over this period. The most recent filing was on .
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 31, 24 | James F YoungDirector | SELL | 5.4K | $8.00 | $43K |
| Dec 24, 24 | James F YoungDirector | SELL | 4.6K | $8.48 | $39K |
| Dec 13, 24 | Rachel K. KingDirector | SELL | 4.2K | $9.02 | $37K |
| Jun 21, 24 | James F YoungDirector | SELL | 7.5K | $14.09 | $106K |
| Jun 18, 24 | James F YoungDirector | SELL | 6.4K | $14.28 | $87K |
| Jun 17, 24 | Filip DubovskyPresident, R&D | SELL | 12.5K | $14.54 | $181K |
| May 14, 24 | Filip DubovskyPresident, R&D | SELL | 47.3K | $13.90 | $658K |
| Mar 10, 23 | Gregory M GlennPresident, R&D | BUY | 1.0K | $6.50 | $7K |
| Mar 7, 23 | Gregory M GlennPresident, R&D | BUY | 2.0K | $7.04 | $14K |
| Mar 6, 23 | Gregory M GlennPresident, R&D | BUY | 3.0K | $7.48 | $22K |
| Mar 31, 22 | James F YoungDirector | SELL | 8.9K | $75.10 | $656K |
| Jan 3, 22 | John A Herrmann IIIEVP, Chief Legal Officer | SELL | 1.0K | $144.43 | $144K |
| Dec 31, 21 | James F YoungDirector | SELL | 3.8K | $144.16 | $541K |
| Dec 20, 21 | John A Herrmann IIIEVP, Chief Legal Officer | SELL | 5.0K | $230.00 | $1.1M |
| Dec 15, 21 | Gregory M GlennPresident, R&D | SELL | 254 | $180.62 | $44K |
| Dec 7, 21 | Gregory M GlennPresident, R&D | SELL | 900 | $182.30 | $158K |
| Dec 1, 21 | John A Herrmann IIIEVP, Chief Legal Officer | SELL | 943 | $202.36 | $185K |
| Nov 30, 21 | Gregory M GlennPresident, R&D | SELL | 1.4K | $211.75 | $303K |
| Nov 29, 21 | John A Herrmann IIIEVP, Chief Legal Officer | SELL | 5.0K | $228.72 | $1.1M |
| Nov 26, 21 | Gregory M GlennPresident, R&D | SELL | 626 | $221.24 | $137K |
| Nov 23, 21 | Gregory M GlennPresident, R&D | SELL | 1.6K | $203.62 | $321K |
| Nov 16, 21 | Gregory M GlennPresident, R&D | SELL | 4.4K | $170.94 | $741K |
| Nov 15, 21 | Gregory M GlennPresident, R&D | SELL | 1.2K | $172.02 | $204K |
| Nov 9, 21 | Gregory M GlennPresident, R&D | SELL | 2.0K | $171.48 | $336K |
| Nov 3, 21 | John A Herrmann IIIEVP, Chief Legal Officer | SELL | 5.0K | $200.00 | $1.0M |
| Nov 2, 21 | Gregory M GlennPresident, R&D | SELL | 1.2K | $196.24 | $214K |
| Nov 1, 21 | John A Herrmann IIIEVP, Chief Legal Officer | SELL | 800 | $173.15 | $126K |
| Oct 29, 21 | Gregory M GlennPresident, R&D | SELL | 353 | $152.16 | $53K |
| Oct 26, 21 | Gregory M GlennPresident, R&D | SELL | 3.1K | $135.16 | $417K |
| Oct 19, 21 | Gregory M GlennPresident, R&D | SELL | 1.6K | $172.03 | $256K |
| Oct 15, 21 | Gregory M GlennPresident, R&D | SELL | 1.2K | $170.00 | $201K |
| Oct 12, 21 | Gregory M GlennPresident, R&D | SELL | 2.9K | $166.78 | $471K |
| Oct 5, 21 | Gregory M GlennPresident, R&D | SELL | 2.2K | $183.14 | $378K |
| Oct 4, 21 | Stanley C ErckPresident and CEO | SELL | 8.9K | $180.58 | $1.6M |
| Oct 1, 21 | Stanley C ErckPresident and CEO | SELL | 6.2K | $190.63 | $1.1M |
| Oct 1, 21 | John A Herrmann IIIEVP, Chief Legal Officer | SELL | 600 | $190.63 | $103K |
| Sep 30, 21 | Gregory M GlennPresident, R&D | SELL | 280 | $210.16 | $58K |
| Sep 28, 21 | John TrizzinoEVP, CCO and CBO | SELL | 1.5K | $230.00 | $298K |
| Sep 27, 21 | Gregory M GlennPresident, R&D | SELL | 318 | $248.13 | $74K |
| Sep 27, 21 | John TrizzinoEVP, CCO and CBO | SELL | 1.4K | $249.04 | $316K |
| Sep 23, 21 | David M MottDirector | SELL | 7.7K | $255.38 | $2.0M |
| Sep 21, 21 | John TrizzinoEVP, CCO and CBO | SELL | 1.5K | $231.11 | $349K |
| Sep 20, 21 | John TrizzinoEVP, CCO and CBO | SELL | 1.3K | $232.90 | $299K |
| Sep 15, 21 | Gregory M GlennPresident, R&D | SELL | 204 | $234.73 | $46K |
| Sep 15, 21 | John A Herrmann IIIEVP, Chief Legal Officer | SELL | 1.1K | $234.90 | $258K |
| Sep 14, 21 | John TrizzinoEVP, CCO and CBO | SELL | 1.4K | $241.70 | $339K |
| Sep 13, 21 | John TrizzinoEVP, CCO and CBO | SELL | 1.3K | $247.33 | $306K |
| Sep 1, 21 | John A Herrmann IIIEVP, Chief Legal Officer | SELL | 600 | $254.83 | $152K |
| Aug 31, 21 | Gregory M GlennPresident, R&D | SELL | 359 | $244.03 | $86K |
| Aug 26, 21 | Gregory M GlennPresident, R&D | SELL | 700 | $240.04 | $163K |
Over the past 12 months, insiders at NOVAVAX INC filed 0 open-market purchases worth $0 and 0 sales worth $0 on NVAX, which makes them mixed over the period. The most recent Form 4 was filed on .
The largest recent open-market NVAX insider purchase in our data was $22K by Gregory M Glenn, President, R&D, filed on Mar 6, 23.
0 different insiders at NOVAVAX INC filed open-market SEC Form 4 transactions on NVAX over the last 12 months.
InsiderTape plots every NVAX insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every NOVAVAX INC insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →